Protective efficacy of a SARS-CoV-2 DNA vaccine in wild-type and immunosuppressed Syrian hamsters.
Protective efficacy of a SARS-CoV-2 DNA vaccine in wild-type and immunosuppressed Syrian hamsters.
复制标题
SARS-CoV-2 DNA疫苗在野生型和免疫抑制的叙利亚仓鼠中的保护效力
DOI:
10.1038/s41541-020-00279-z
复制
发表时间:
2021-01-25
期刊:
影响因子:
9.2
通讯作者:
Hooper JW
中科院分区:
文献类型:
--
作者:
Brocato RL;Kwilas SA;Kim RK;Zeng X;Principe LM;Smith JM;Hooper JW
A worldwide effort to counter the COVID-19 pandemic has resulted in hundreds of candidate vaccines moving through various stages of research and development, including several vaccines in phase 1, 2 and 3 clinical trials. A relatively small number of these vaccines have been evaluated in SARS-CoV-2 disease models, and fewer in a severe disease model. Here, a SARS-CoV-2 DNA targeting the spike protein and delivered by jet injection, nCoV-S(JET), elicited neutralizing antibodies in hamsters and was protective in both wild-type and transiently immunosuppressed hamster models. This study highlights the DNA vaccine, nCoV-S(JET), we developed has a great potential to move to next stage of preclinical studies, and it also demonstrates that the transiently-immunosuppressed Syrian hamsters, which recapitulate severe and prolonged COVID-19 disease, can be used for preclinical evaluation of the protective efficacy of spike-based COVID-19 vaccines.
登录
查看更多内容
影响因子:
3.6
作者:
Kwilas S;Kishimori JM;Josleyn M;Jerke K;Ballantyne J;Royals M;Hooper JW
通讯作者:
Hooper JW
影响因子:
30.3
作者:
Case, James Brett;Rothlauf, Paul W.;Whelan, Sean P. J.
通讯作者:
Whelan, Sean P. J.
影响因子:
5.4
作者:
Brocato RL;Principe LM;Kim RK;Zeng X;Williams JA;Liu Y;Li R;Smith JM;Golden JW;Gangemi D;Youssef S;Wang Z;Glanville J;Hooper JW
通讯作者:
Hooper JW
影响因子:
11.8
作者:
Furukawa, Nathan W;Brooks, John T;Sobel, Jeremy
通讯作者:
Sobel, Jeremy
影响因子:
56.9
作者:
Yu, Jingyou;Tostanoski, Lisa H.;Barouch, Dan H.
通讯作者:
Barouch, Dan H.